EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Hypertrophic Cardiomyopathy and the Risk of Bradyarrhythmia and Permanent Pacemaker Implantation: A Nationwide Cohort Study

Tsu-An Yang, Yu-Yu Hsiao iD, Shang-Ju Wu iD, Yu-Shan Chien, Ming-Jen Kuo, Yu-Shan Huang, Guan-Yi Li iD, Ching-Heng Lin, Cheng-Hung Li, Jiunn-Cherng Lin, Jin-Long Huang iD, Yun-Yu Chen und 4 weitere

Clinical Cardiology · 2026

DOI: 10.1002/clc.70454 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Cardiology, 2026. Verfasst von Tsu-An Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Changhua Christian Hospital, Changhua, Taiwan. Hauptthemen laut MEDLINE: Bradycardia, Cardiac Pacing, Artificial, Cardiomyopathy, Hypertrophic, Pacemaker, Artificial. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taichung Veterans General Hospital., Taichung Veterans General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertrophic cardiomyopathy (HCM) is associated with various arrhythmias, including bradyarrhythmia. The relationship between HCM and bradyarrhythmia, and subsequent need for permanent pacemaker (PPM) implantation, remains unclear. This study aimed to evaluate the risk of bradyarrhythmia and PPM implantation in HCM patients.

Methods

This retrospective, population‐based cohort study identified patients with newly diagnosed HCM from 2012 to 2017 in Taiwan's National Health Insurance Research Database. Patients with prior bradyarrhythmia or PPM implantation were excluded. A control cohort was selected by matching patients without HCM to the study cohort by age and gender in a 1:1 ratio. The primary and secondary outcomes were the occurrence of bradyarrhythmia and PPM implantation, respectively. A multivariate Cox proportional hazards regression model was used to evaluate the hazard ratios (HR) for the outcomes.

Results

A total of 15 266 patients with a mean age of 63.8 ± 14.5 years constituted the HCM ( n = 7633) and control ( n = 7633) cohorts. During a follow‐up period of 4.05 ± 2.03 years, HCM was associated with higher risks of bradyarrhythmia (adjusted HR: 2.15, p < 0.001) and PPM implantation (adjusted HR: 6.58, p < 0.001). In patients with HCM, the presence of AF increased the risks of both bradyarrhythmia (adjusted HR: 1.61, p < 0.001) and PPM implantation (adjusted HR: 2.12, p < 0.001), while HF increased the risks of PPM implantation (adjusted HR: 1.61, p < 0.001).

Conclusions

Patients with HCM had higher risks of bradyarrhythmia and PPM implantation. Patients with HCM should be carefully monitored for AF and HF, which might increase the risks of future PPM implantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BradycardiaCardiac Pacing, ArtificialCardiomyopathy, HypertrophicPacemaker, ArtificialAgedFemaleHumansMaleMiddle AgedFollow-Up StudiesIncidenceRetrospective StudiesRisk AssessmentRisk FactorsTaiwanTime Factors

Stichwörter der Autor:innen

atrial fibrillationbradyarrhythmiahypertrophic cardiomyopathypermanent pacemakersick sinus syndrome

Autor:innen und Institutionen

  • Department of Family Medicine, Changhua Christian Hospital, Changhua, Taiwan.
  • Cardiovascular Center and Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Internal Medicine, Faculty of Medicine, Institute of Clinical Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.
  • Department of Data Science and Big Data Analytics, and Department of Financial Engineering, Providence University, Taichung, Taiwan.
  • Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Post-Baccalaureate Medicine, Cardiovascular Research Center, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

ORCID-Profile: Yu-Yu Hsiao, Shang-Ju Wu, Guan-Yi Li, Jin-Long Huang, Li-Wei Lo, Yenn-Jiang Lin, Yu-Cheng Hsieh

Förderung

  • Taichung Veterans General Hospital.
  • Taichung Veterans General Hospital

Zitieren

APA

Yang, T. A., Hsiao, Y. Y., Wu, S. J., Chien, Y. S., Kuo, M. J., Huang, Y. S., Li, G. Y., Lin, C. H., Li, C. H., Lin, J. C., Huang, J. L., Chen, Y. Y., Lo, L. W., Lin, Y. J., Hsieh, Y. C., & Chen, S. A. (2026). Hypertrophic Cardiomyopathy and the Risk of Bradyarrhythmia and Permanent Pacemaker Implantation: A Nationwide Cohort Study. Clinical Cardiology. https://doi.org/10.1002/clc.70454

Vancouver

Yang TA, Hsiao YY, Wu SJ, Chien YS, Kuo MJ, Huang YS, et al. Hypertrophic Cardiomyopathy and the Risk of Bradyarrhythmia and Permanent Pacemaker Implantation: A Nationwide Cohort Study. Clinical Cardiology. 2026. doi:10.1002/clc.70454

BibTeX
@article{Yang2026,
  author = {Yang, Tsu-An and Hsiao, Yu-Yu and Wu, Shang-Ju and Chien, Yu-Shan and Kuo, Ming-Jen and Huang, Yu-Shan and Li, Guan-Yi and Lin, Ching-Heng and Li, Cheng-Hung and Lin, Jiunn-Cherng and Huang, Jin-Long and Chen, Yun-Yu and Lo, Li-Wei and Lin, Yenn-Jiang and Hsieh, Yu-Cheng and Chen, Shih-Ann},
  title = {Hypertrophic Cardiomyopathy and the Risk of Bradyarrhythmia and Permanent Pacemaker Implantation: A Nationwide Cohort Study},
  journal = {Clinical Cardiology},
  year = {2026},
  doi = {10.1002/clc.70454}
}
Kostenlos starten →